BPSA European Summit

Date: 26 September 2018 - 28 September 2018

Location:
Crowne Plaza Barcelona
Fira Center Av. de Rius i Taulet
1, 08004 Barcelona

Spain

Website: http://bpsalliance.org/bpsa-european-summit/

Please mark your calendars for a unique event focused on polymer-based bio-processing and cell and gene therapies enabled by Single-Use Technologies

Innovation and commercialisation of the next generation of opportunities in single-use processing and cell therapies will be a key focus of the Bio-Process Systems Alliance (BPSA) 2nd International Single-Use Summit, 26-28 September, in Barcelona, Spain.

The Summit includes a mix of technical and pertinent European regulatory matters that highlight the critical need for innovation in the polymer-based bioprocessing industry, to accelerate and advance life-saving cell-growth and cell-harvested immunotherapies.

The BPSA-sponsored Barcelona Summit will feature a unique blend of technical and innovation topics for company leaders across the globe with a business stake in single-use systems as users and providers.

The conference will focus on key issues, to include the current business climate for single-use, European Union regulatory insights, market growth potentials, as well as the positive attributes of single-use systems, which make them safe, reliable, cost-effective and sustainable.

Featured in speakers are:

Barbara Paldus, General Partner, Sekhmet Limited, who will deliver a forward-looking perspective around biotechnology, bioprocessing, cell, gene and tissue therapy advances, and how 3-D printing, high-speed quantum computing and nanotechnology will feature in the creation and delivery of advanced medicines, replacement organs and immunotherapies. 

Uwe Gottschalk, Chief Scientific Officer, Lonza (Switzerland), who will describe single-use in the context of personalised medicine paradigms. 

Cesar Triguerous, Chief Science, Viralgen (Spain), who will speak to the market potential and supply of viral vectors, now far below demand.  

Jose Castillo, Chief Technology Officer, Univercells (Belgium) on innovations in micro-facility flexible manufacturing projects.

Nino Mihokovic, Quality of Medicines Specialist, EMA (UK), who will address the European Medicines Agency (EMA) perspectives and experiences with polymer-based bio-processing systems.  

Closed Systems and Integrity Assurance will be addressed in a panel discussion to speak to the assurance of CCI, including principles around QRM, QbD, quality and process control, and integrity testing practices.

Rounding out the Summit are panel discussions on a variety of topics impacting the industry, to include a panel on plastics and sustainability, facilitated by Cristina Amorim of Thermo-Fisher Scientific, chair of the BPSA Sustainability Council. 

The Barcelona Summit will present the global impact of single-use on modern medicine – real, potential and imagined. The Summit is not only focused on the proven effectiveness of legacy plastic bioprocessing platforms, but also on the ‘next wave’ of business opportunities, with an eye toward GMP, workforce excellence and sustainability,” said BPSA Executive Director Kevin Ott.  Participation is anticipated with the attendance of delegates from Spain, France, Belgium, Netherlands, USA, United Kingdom, Canada and Eastern Europe. 

The Summit will be held at the Crowne Plaza in Barcelona. Registration and hotel information can be viewed at www.bpsalliance.org.

For more information, click here. 

Map